The New York State Department of Health has awarded a contract to Roswell Park Cancer Institute to continue funding the New York State Smokers’ Quitline. The five-year, $20.6 million contract will enable Roswell Park to provide comprehensive telephonic services, online resources, and services for healthcare providers to help tobacco users successfully quit. The grant will... […]
Peter Pisters has been named president of MD Anderson Cancer Center and will begin in his new role later this year.
NCI has released its professional judgment budget proposal for the fiscal year 2019, requesting $6.38 billion—$1 billion more than FY17—to fully fund promising areas in cancer research.
In a 6-6 vote, ODAC says “maybe” to Sutent for adjuvant kidney cancer—
But at FDA “Maybe” has meaning
With frustrating photo finish voting results—6-6—still on the screen, FDA's cancer czar Richard Pazdur delivered an acerbic thank-you to members of the agency's Oncologic Drugs Advisory Committee:“Well, that's the end vote, it makes our job definitely easier,” said Pazdur, director of the FDA's Oncology Center of Excellence, who gets sarcastic sometimes.
The American Society for Radiation Oncology is awarding $275,000 in research awards to four early-career scientists as part of the society’s efforts to retain and foster the intellectual research talent currently entering the field of radiation oncology. For 2017, the Research Grants committee selected one Junior Faculty Award and three Resident Seed Grant recipients. All... […]
Five UC Comprehensive Cancer Centers form consortium to pool patient data for translational research
Five academic cancer centers within the University of California system are putting together a single consortium to integrate their electronic health records, forming a clinical trials monolith that could be used by pharmaceutical companies doing research in the Golden State.
As the inaugural chair of the University of California Cancer Consortium, Alan Ashworth has to do a little cheerleading and a lot of pushing for integration of the electronic health records across the UC cancer centers.
FDA has a legitimate role to play in slowing down the cost of developing drugs, and it can do so by relying on good regulatory science, the agency's commissioner Scott Gottlieb said.
The Next Step is an occasional series of conversations in which The Cancer Letter will focus on cancer researchers in the midst of transition from one position to another.
Michael Teitell, a molecular immunologist and biochemist, was named director of the UCLA Jonsson Comprehensive Cancer Center and president of the Jonsson Cancer Center Foundation.
